Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review
European Journal of Cancer Care · 2022-11 · 31 (6)
DOI: 10.1111/ecc.13669 ↗At a glance
Systematische Übersicht in European Journal of Cancer Care, published online on 2022-08-07. Written by Shahla Ostovar and 5 co-authors. Institution: School of Social Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia. Major MEDLINE topics: Psychological Distress, Neoplasms. Cited 38 times so far (Crossref); 102 references. The full text is freely available (open access, CC BY-NC 4.0).
Topics: Onkologische Pflege
Abstract (original language)
Psychological distress (including depression and anxiety) is common in the first years of cancer diagnosis but can differ by country and region. The aim of the present paper was to review the prevalence of psychological distress among cancer patients in the Southeast Asia (SEA) region. A systematic literature search was carried out using several databases (i.e., PubMed, PsychARTICLES, Embase, CINAHI, Web of Sciences, Plus, Scopus, and AHMED). Papers originally published in English language were taken into consideration if they (i) were published from 2010 to 2021 and (ii) reported the prevalence of psychological distress among patients with different types of cancer. A total of 23 studies met the inclusion criteria. The most frequently employed psychometric instrument for anxiety and depression screening was the Hospital Anxiety and Depression Scale (HADS). The prevalence of anxiety (ranging from 7% to 88%) was wider than that of depression (ranging from 3% to 65.5%) among patients with different types of cancer and living in various countries in the SEA region. The overall prevalence rate of psychological distress among cancer patients from the SEA region was not fundamentally very different from that of general populations. These findings provide useful information for health professionals and cancer patients to understand the negative role of psychological distress in quality of life and health. The research findings demonstrate the importance of counselling for psychological distress among cancer patients as means of effectively resolving their psychological problems and ultimately improving the quality of oncology medical care. Clinical recommendations for cancer management should incorporate the early identification of (and therapy for) psychological distress, as well as their monitoring during treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Social Sciences, Universiti Sains Malaysia, Minden, Penang, Malaysia.
- Integrative Medicine Cluster Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Pulau Pinang, Malaysia.
- Department of Paediatrics, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Faculty of Physical Culture and Health, University of Szczecin, Szczecin, Poland.
- Psychology Department, Nottingham Trent University, Nottingham, UK.
ORCID profiles: Shahla Ostovar, Azizah Othman, Mark D Griffiths
Cite
APA
Ostovar, S., Modarresi Chahardehi, A., Mohd Hashim, I. H., Othman, A., Kruk, J., & Griffiths, M. D. (2022). Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review. European Journal of Cancer Care, 31(6). https://doi.org/10.1111/ecc.13669
Vancouver
Ostovar S, Modarresi Chahardehi A, Mohd Hashim IH, Othman A, Kruk J, Griffiths MD. Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review. European Journal of Cancer Care. 2022;31(6). doi:10.1111/ecc.13669
BibTeX
@article{Ostovar2022,
author = {Ostovar, Shahla and Modarresi Chahardehi, Amir and Mohd Hashim, Intan Hashimah and Othman, Azizah and Kruk, Joanna and Griffiths, Mark D},
title = {Prevalence of psychological distress among cancer patients in Southeast Asian countries: A systematic review},
journal = {European Journal of Cancer Care},
year = {2022},
volume = {31},
number = {6},
doi = {10.1111/ecc.13669}
}
EUVIMED